1. Topic: AS06-Prognosis/AS06a-Prognostic factors of outcome and risk assessment: PROGNOSTIC SIGNIFICANCE OF COMORBIDITIES AND FRAILTY IN RISK STRATIFICATION OF PATIENTS WITH MYELODYSPLASTIC SYNDROME. (September 2021) Authors: Efraim, M.; Micheva, I. Journal: Leukemia research Issue: Volume 108(2021)Supplement Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. S291: PHASE I/II STUDY OF RILZABRUTINIB, AN ORAL BRUTON TYROSINE KINASE INHIBITOR, IN PATIENTS WITH IMMUNE THROMBOCYTOPENIA: LONG-TERM FOLLOW-UP. (23rd June 2022) Authors: Kuter, D. J.; Efraim, M.; Kaplan, Z.; Mayer, J.; Choi, P.; Jansen, A. G.; McDonald, V.; Baker, R.; Bird, R.; Garg, M.; Gumulec, J.; Kostal, M.; Gernsheimer, T.; Ghanima, W.; Yao, M.; Daak, A.; Cooper, N. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 192 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗